Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novartis presents novel anti-BAFF-R afucosylated human antibody

Dec. 11, 2013

Pharmacological data presented for a selective nAChR desensitizer

Dec. 11, 2013

Sunovion presents the discovery of novel selective mGlu5 PAMs

Dec. 11, 2013

Novel CB2 agonists demonstrate efficacy in animal models of inflammatory pain

Dec. 11, 2013

ImQuest BioSciences presents a novel anti-HIV microbicide gel

Dec. 11, 2013

Development of novel 5-HT2C PAMs for neurological disorders

Dec. 10, 2013

First-in-human phase I study reported for SGN-CD19A

Dec. 10, 2013

Characterization of novel cocaine metabolizing enzymes for treatment of addiction

Dec. 10, 2013

Phase Ib data for MP-4-CO in patients with sickle cell anemia

Dec. 9, 2013

MUC-1 cancer vaccine well tolerated in phase I study

Dec. 9, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...